{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"provenance":[],"authorship_tag":"ABX9TyNvKLZ48zzG6bSRv7bzTuYS"},"kernelspec":{"name":"python3","display_name":"Python 3"},"language_info":{"name":"python"}},"cells":[{"cell_type":"code","execution_count":1,"metadata":{"id":"Phdu3ZeGiYbe","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1760409920171,"user_tz":-540,"elapsed":20744,"user":{"displayName":"Di Lab","userId":"16690045528125560783"}},"outputId":"defd0ffa-e44b-4608-a867-780f487cd3fc"},"outputs":[{"output_type":"stream","name":"stdout","text":["Mounted at /content/drive\n"]}],"source":["from google.colab import drive\n","\n","# 구글 드라이브 마운트\n","drive.mount('/content/drive')\n","\n","# 마운트 후 경로 예시\n","# /content/drive/MyDrive/ 경로에 파일이 있음\n"]},{"cell_type":"code","source":["import pandas as pd\n","\n","file_path = \"/content/drive/MyDrive/DILAB/MARS/mimic-iv-note_2.2/files/note/discharge.csv\"\n","\n","pd.set_option(\"display.max_colwidth\", None)  # 열 너비 제한 해제\n","pd.set_option(\"display.width\", 0)            # 자동 줄바꿈(터미널/노트북 폭에 맞춤)\n","pd.set_option(\"display.max_rows\", 200)       # 필요 시 행 표시 개수 늘리기\n","\n","print(df.head(1).to_string(index=False))     # … 없이 풀로 출력\n","\n"],"metadata":{"id":"Bn9Uv05yikqJ","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1760410013700,"user_tz":-540,"elapsed":32,"user":{"displayName":"Di Lab","userId":"16690045528125560783"}},"outputId":"2dd90cb3-15cb-499a-8a8f-ae6e3a2c0634"},"execution_count":3,"outputs":[{"output_type":"stream","name":"stdout","text":["       note_id  subject_id  hadm_id note_type  note_seq           charttime           storetime                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   text\n","10000032-DS-21    10000032 22595853        DS        21 2180-05-07 00:00:00 2180-05-09 15:26:00  \\nName:  ___                     Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\nAttending: ___\\n \\nChief Complaint:\\nWorsening ABD distension and pain \\n \\nMajor Surgical or Invasive Procedure:\\nParacentesis\\n\\n \\nHistory of Present Illness:\\n___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \\nbioplar, PTSD, presented from OSH ED with worsening abd \\ndistension over past week.  \\nPt reports self-discontinuing lasix and spirnolactone ___ weeks \\nago, because she feels like \"they don't do anything\" and that \\nshe \"doesn't want to put more chemicals in her.\" She does not \\nfollow Na-restricted diets. In the past week, she notes that she \\nhas been having worsening abd distension and discomfort. She \\ndenies ___ edema, or SOB, or orthopnea. She denies f/c/n/v, d/c, \\ndysuria. She had food poisoning a week ago from eating stale \\ncake (n/v 20 min after food ingestion), which resolved the same \\nday. She denies other recent illness or sick contacts. She notes \\nthat she has been noticing gum bleeding while brushing her teeth \\nin recent weeks. she denies easy bruising, melena, BRBPR, \\nhemetesis, hemoptysis, or hematuria.  \\nBecause of her abd pain, she went to OSH ED and was transferred \\nto ___ for further care. Per ED report, pt has brief period of \\nconfusion - she did not recall the ultrasound or bloodwork at \\nosh. She denies recent drug use or alcohol use. She denies \\nfeeling confused, but reports that she is forgetful at times.  \\nIn the ED, initial vitals were 98.4 70 106/63 16 97%RA  \\nLabs notable for ALT/AST/AP ___ ___: ___, \\nTbili1.6, WBC 5K, platelet 77, INR 1.6  \\n\\n \\nPast Medical History:\\n1. HCV Cirrhosis  \\n2. No history of abnormal Pap smears.  \\n3. She had calcification in her breast, which was removed  \\npreviously and per patient not, it was benign.  \\n4. For HIV disease, she is being followed by Dr. ___ Dr.  \\n___.  \\n5. COPD  \\n6. Past history of smoking.  \\n7. She also had a skin lesion, which was biopsied and showed  \\nskin cancer per patient report and is scheduled for a complete  \\nremoval of the skin lesion in ___ of this year.  \\n8. She also had another lesion in her forehead with purple  \\ndiscoloration. It was biopsied to exclude the possibility of  \\n___'s sarcoma, the results is pending.  \\n9. A 15 mm hypoechoic lesion on her ultrasound on ___  \\nand is being monitored by an MRI.  \\n10. History of dysplasia of anus in ___.  \\n11. Bipolar affective disorder, currently manic, mild, and PTSD. \\n \\n12. History of cocaine and heroin use.  \\n\\n \\nSocial History:\\n___\\nFamily History:\\nShe a total of five siblings, but she is not  \\ntalking to most of them. She only has one brother that she is in \\n \\ntouch with and lives in ___. She is not aware of any  \\nknown GI or liver disease in her family.  \\nHer last alcohol consumption was one drink two months ago. No  \\nregular alcohol consumption. Last drug use ___ years ago. She  \\nquit smoking a couple of years ago.  \\n\\n \\nPhysical Exam:\\nVS: 98.1 107/61 78 18 97RA  \\nGeneral: in NAD  \\nHEENT: CTAB, anicteric sclera, OP clear  \\nNeck: supple, no LAD  \\nCV: RRR,S1S2, no m/r/g  \\nLungs: CTAb, prolonged expiratory phase, no w/r/r  \\nAbdomen: distended, mild diffuse tenderness, +flank dullness, \\ncannot percuss liver/spleen edge ___ distension  \\nGU: no foley  \\nExt: wwp, no c/e/e, + clubbing  \\nNeuro: AAO3, converse normally, able to recall 3 times after 5 \\nminutes, CN II-XII intact  \\n\\nDischarge:\\n\\nPHYSICAL EXAMINATION:  \\nVS: 98 105/70 95\\nGeneral: in NAD  \\nHEENT: anicteric sclera, OP clear  \\nNeck: supple, no LAD  \\nCV: RRR,S1S2, no m/r/g  \\nLungs: CTAb, prolonged expiratory phase, no w/r/r  \\nAbdomen: distended but improved, TTP in RUQ, \\nGU: no foley  \\nExt: wwp, no c/e/e, + clubbing  \\nNeuro: AAO3,  CN II-XII intact  \\n\\n \\nPertinent Results:\\n___ 10:25PM   GLUCOSE-109* UREA N-25* CREAT-0.3* SODIUM-138 \\nPOTASSIUM-3.4 CHLORIDE-105 TOTAL CO2-27 ANION GAP-9\\n___ 10:25PM   estGFR-Using this\\n___ 10:25PM   ALT(SGPT)-100* AST(SGOT)-114* ALK PHOS-114* \\nTOT BILI-1.6*\\n___ 10:25PM   LIPASE-77*\\n___ 10:25PM   ALBUMIN-3.3*\\n___ 10:25PM   WBC-5.0# RBC-4.29 HGB-14.3 HCT-42.6 MCV-99* \\nMCH-33.3* MCHC-33.5 RDW-15.7*\\n___ 10:25PM   NEUTS-70.3* LYMPHS-16.5* MONOS-8.1 EOS-4.2* \\nBASOS-0.8\\n___ 10:25PM   PLT COUNT-71*\\n___ 10:25PM   ___ PTT-30.9 ___\\n___ 10:25PM   ___\\n.\\n\\nCXR: No acute cardiopulmonary process.  \\nU/S:  \\n1. Nodular appearance of the liver compatible with cirrhosis. \\nSigns of portal  \\nhypertension including small amount of ascites and splenomegaly. \\n \\n2. Cholelithiasis.  \\n3. Patent portal veins with normal hepatopetal flow.  \\nDiagnostic para attempted in the ED, unsuccessful.  \\nOn the floor, pt c/o abd distension and discomfort.\\n \\nBrief Hospital Course:\\n___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \\nbioplar, PTSD, presented from OSH ED with worsening abd \\ndistension over past week and confusion.  \\n\\n# Ascites - p/w worsening abd distension and discomfort for last \\nweek. likely ___ portal HTN given underlying liver disease, \\nthough no ascitic fluid available on night of admission. No \\nsigns of heart failure noted on exam. This was ___ to med \\nnon-compliance and lack of diet restriction. SBP negative\\ndiuretics:  \\n> Furosemide 40 mg PO DAILY  \\n> Spironolactone 50 mg PO DAILY, chosen over the usual 100mg \\ndose d/t K+ of 4.5.   \\n CXR was wnl, UA negative, Urine culture blood culture negative. \\n \\nPt was losing excess fluid appropriately with stable lytes on \\nthe above regimen. Pt was scheduled with current PCP for \\n___ check upon discharge.   \\nPt was scheduled for new PCP with Dr. ___ at ___ and \\nfollow up in Liver clinic to schedule outpatient screening EGD \\nand ___.   \\n \\n\\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Furosemide 20 mg PO DAILY \\n2. Spironolactone 50 mg PO DAILY \\n3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \\n4. Raltegravir 400 mg PO BID \\n5. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \\n6. Nicotine Patch 14 mg TD DAILY \\n7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \\n\\n \\nDischarge Medications:\\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \\n2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \\n3. Furosemide 40 mg PO DAILY \\nRX *furosemide 40 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet \\nRefills:*3\\n4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \\n5. Nicotine Patch 14 mg TD DAILY \\n6. Raltegravir 400 mg PO BID \\n7. Spironolactone 50 mg PO DAILY \\n8. Acetaminophen 500 mg PO Q6H:PRN pain \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nAscites from Portal HTN\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear Ms. ___,\\nIt was a pleasure taking care of you! You came to us with \\nstomach pain and worsening distension. While you were here we \\ndid a paracentesis to remove 1.5L of fluid from your belly. We \\nalso placed you on you 40 mg of Lasix and 50 mg of Aldactone to \\nhelp you urinate the excess fluid still in your belly. As we \\ndiscussed, everyone has a different dose of lasix required to \\nmake them urinate and it's likely that you weren't taking a high \\nenough dose. Please take these medications daily to keep excess \\nfluid off and eat a low salt diet. You will follow up with Dr. \\n___ in liver clinic and from there have your colonoscopy \\nand EGD scheduled. Of course, we are always here if you need us. \\nWe wish you all the best!\\nYour ___ Team.  \\n \\nFollowup Instructions:\\n___\\n\n"]}]},{"cell_type":"code","source":["print(df[\"text\"].head(1).to_string(index=False))\n","\n","# 특정 행의 텍스트만 정확히 하나 뽑기\n","print(df.loc[0, \"text\"])        # 또는\n","print(df.iloc[0][\"text\"])"],"metadata":{"id":"4Cll6Iv3pfZh","executionInfo":{"status":"ok","timestamp":1760410599033,"user_tz":-540,"elapsed":79,"user":{"displayName":"Di Lab","userId":"16690045528125560783"}},"outputId":"d42fcbcc-d050-4142-e915-e4bcbdf3acef","colab":{"base_uri":"https://localhost:8080/"}},"execution_count":4,"outputs":[{"output_type":"stream","name":"stdout","text":[" \\nName:  ___                     Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\nAttending: ___\\n \\nChief Complaint:\\nWorsening ABD distension and pain \\n \\nMajor Surgical or Invasive Procedure:\\nParacentesis\\n\\n \\nHistory of Present Illness:\\n___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \\nbioplar, PTSD, presented from OSH ED with worsening abd \\ndistension over past week.  \\nPt reports self-discontinuing lasix and spirnolactone ___ weeks \\nago, because she feels like \"they don't do anything\" and that \\nshe \"doesn't want to put more chemicals in her.\" She does not \\nfollow Na-restricted diets. In the past week, she notes that she \\nhas been having worsening abd distension and discomfort. She \\ndenies ___ edema, or SOB, or orthopnea. She denies f/c/n/v, d/c, \\ndysuria. She had food poisoning a week ago from eating stale \\ncake (n/v 20 min after food ingestion), which resolved the same \\nday. She denies other recent illness or sick contacts. She notes \\nthat she has been noticing gum bleeding while brushing her teeth \\nin recent weeks. she denies easy bruising, melena, BRBPR, \\nhemetesis, hemoptysis, or hematuria.  \\nBecause of her abd pain, she went to OSH ED and was transferred \\nto ___ for further care. Per ED report, pt has brief period of \\nconfusion - she did not recall the ultrasound or bloodwork at \\nosh. She denies recent drug use or alcohol use. She denies \\nfeeling confused, but reports that she is forgetful at times.  \\nIn the ED, initial vitals were 98.4 70 106/63 16 97%RA  \\nLabs notable for ALT/AST/AP ___ ___: ___, \\nTbili1.6, WBC 5K, platelet 77, INR 1.6  \\n\\n \\nPast Medical History:\\n1. HCV Cirrhosis  \\n2. No history of abnormal Pap smears.  \\n3. She had calcification in her breast, which was removed  \\npreviously and per patient not, it was benign.  \\n4. For HIV disease, she is being followed by Dr. ___ Dr.  \\n___.  \\n5. COPD  \\n6. Past history of smoking.  \\n7. She also had a skin lesion, which was biopsied and showed  \\nskin cancer per patient report and is scheduled for a complete  \\nremoval of the skin lesion in ___ of this year.  \\n8. She also had another lesion in her forehead with purple  \\ndiscoloration. It was biopsied to exclude the possibility of  \\n___'s sarcoma, the results is pending.  \\n9. A 15 mm hypoechoic lesion on her ultrasound on ___  \\nand is being monitored by an MRI.  \\n10. History of dysplasia of anus in ___.  \\n11. Bipolar affective disorder, currently manic, mild, and PTSD. \\n \\n12. History of cocaine and heroin use.  \\n\\n \\nSocial History:\\n___\\nFamily History:\\nShe a total of five siblings, but she is not  \\ntalking to most of them. She only has one brother that she is in \\n \\ntouch with and lives in ___. She is not aware of any  \\nknown GI or liver disease in her family.  \\nHer last alcohol consumption was one drink two months ago. No  \\nregular alcohol consumption. Last drug use ___ years ago. She  \\nquit smoking a couple of years ago.  \\n\\n \\nPhysical Exam:\\nVS: 98.1 107/61 78 18 97RA  \\nGeneral: in NAD  \\nHEENT: CTAB, anicteric sclera, OP clear  \\nNeck: supple, no LAD  \\nCV: RRR,S1S2, no m/r/g  \\nLungs: CTAb, prolonged expiratory phase, no w/r/r  \\nAbdomen: distended, mild diffuse tenderness, +flank dullness, \\ncannot percuss liver/spleen edge ___ distension  \\nGU: no foley  \\nExt: wwp, no c/e/e, + clubbing  \\nNeuro: AAO3, converse normally, able to recall 3 times after 5 \\nminutes, CN II-XII intact  \\n\\nDischarge:\\n\\nPHYSICAL EXAMINATION:  \\nVS: 98 105/70 95\\nGeneral: in NAD  \\nHEENT: anicteric sclera, OP clear  \\nNeck: supple, no LAD  \\nCV: RRR,S1S2, no m/r/g  \\nLungs: CTAb, prolonged expiratory phase, no w/r/r  \\nAbdomen: distended but improved, TTP in RUQ, \\nGU: no foley  \\nExt: wwp, no c/e/e, + clubbing  \\nNeuro: AAO3,  CN II-XII intact  \\n\\n \\nPertinent Results:\\n___ 10:25PM   GLUCOSE-109* UREA N-25* CREAT-0.3* SODIUM-138 \\nPOTASSIUM-3.4 CHLORIDE-105 TOTAL CO2-27 ANION GAP-9\\n___ 10:25PM   estGFR-Using this\\n___ 10:25PM   ALT(SGPT)-100* AST(SGOT)-114* ALK PHOS-114* \\nTOT BILI-1.6*\\n___ 10:25PM   LIPASE-77*\\n___ 10:25PM   ALBUMIN-3.3*\\n___ 10:25PM   WBC-5.0# RBC-4.29 HGB-14.3 HCT-42.6 MCV-99* \\nMCH-33.3* MCHC-33.5 RDW-15.7*\\n___ 10:25PM   NEUTS-70.3* LYMPHS-16.5* MONOS-8.1 EOS-4.2* \\nBASOS-0.8\\n___ 10:25PM   PLT COUNT-71*\\n___ 10:25PM   ___ PTT-30.9 ___\\n___ 10:25PM   ___\\n.\\n\\nCXR: No acute cardiopulmonary process.  \\nU/S:  \\n1. Nodular appearance of the liver compatible with cirrhosis. \\nSigns of portal  \\nhypertension including small amount of ascites and splenomegaly. \\n \\n2. Cholelithiasis.  \\n3. Patent portal veins with normal hepatopetal flow.  \\nDiagnostic para attempted in the ED, unsuccessful.  \\nOn the floor, pt c/o abd distension and discomfort.\\n \\nBrief Hospital Course:\\n___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \\nbioplar, PTSD, presented from OSH ED with worsening abd \\ndistension over past week and confusion.  \\n\\n# Ascites - p/w worsening abd distension and discomfort for last \\nweek. likely ___ portal HTN given underlying liver disease, \\nthough no ascitic fluid available on night of admission. No \\nsigns of heart failure noted on exam. This was ___ to med \\nnon-compliance and lack of diet restriction. SBP negative\\ndiuretics:  \\n> Furosemide 40 mg PO DAILY  \\n> Spironolactone 50 mg PO DAILY, chosen over the usual 100mg \\ndose d/t K+ of 4.5.   \\n CXR was wnl, UA negative, Urine culture blood culture negative. \\n \\nPt was losing excess fluid appropriately with stable lytes on \\nthe above regimen. Pt was scheduled with current PCP for \\n___ check upon discharge.   \\nPt was scheduled for new PCP with Dr. ___ at ___ and \\nfollow up in Liver clinic to schedule outpatient screening EGD \\nand ___.   \\n \\n\\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Furosemide 20 mg PO DAILY \\n2. Spironolactone 50 mg PO DAILY \\n3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \\n4. Raltegravir 400 mg PO BID \\n5. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \\n6. Nicotine Patch 14 mg TD DAILY \\n7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \\n\\n \\nDischarge Medications:\\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \\n2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \\n3. Furosemide 40 mg PO DAILY \\nRX *furosemide 40 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet \\nRefills:*3\\n4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \\n5. Nicotine Patch 14 mg TD DAILY \\n6. Raltegravir 400 mg PO BID \\n7. Spironolactone 50 mg PO DAILY \\n8. Acetaminophen 500 mg PO Q6H:PRN pain \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nAscites from Portal HTN\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear Ms. ___,\\nIt was a pleasure taking care of you! You came to us with \\nstomach pain and worsening distension. While you were here we \\ndid a paracentesis to remove 1.5L of fluid from your belly. We \\nalso placed you on you 40 mg of Lasix and 50 mg of Aldactone to \\nhelp you urinate the excess fluid still in your belly. As we \\ndiscussed, everyone has a different dose of lasix required to \\nmake them urinate and it's likely that you weren't taking a high \\nenough dose. Please take these medications daily to keep excess \\nfluid off and eat a low salt diet. You will follow up with Dr. \\n___ in liver clinic and from there have your colonoscopy \\nand EGD scheduled. Of course, we are always here if you need us. \\nWe wish you all the best!\\nYour ___ Team.  \\n \\nFollowup Instructions:\\n___\\n\n"," \n","Name:  ___                     Unit No:   ___\n"," \n","Admission Date:  ___              Discharge Date:   ___\n"," \n","Date of Birth:  ___             Sex:   F\n"," \n","Service: MEDICINE\n"," \n","Allergies: \n","No Known Allergies / Adverse Drug Reactions\n"," \n","Attending: ___\n"," \n","Chief Complaint:\n","Worsening ABD distension and pain \n"," \n","Major Surgical or Invasive Procedure:\n","Paracentesis\n","\n"," \n","History of Present Illness:\n","___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \n","bioplar, PTSD, presented from OSH ED with worsening abd \n","distension over past week.  \n","Pt reports self-discontinuing lasix and spirnolactone ___ weeks \n","ago, because she feels like \"they don't do anything\" and that \n","she \"doesn't want to put more chemicals in her.\" She does not \n","follow Na-restricted diets. In the past week, she notes that she \n","has been having worsening abd distension and discomfort. She \n","denies ___ edema, or SOB, or orthopnea. She denies f/c/n/v, d/c, \n","dysuria. She had food poisoning a week ago from eating stale \n","cake (n/v 20 min after food ingestion), which resolved the same \n","day. She denies other recent illness or sick contacts. She notes \n","that she has been noticing gum bleeding while brushing her teeth \n","in recent weeks. she denies easy bruising, melena, BRBPR, \n","hemetesis, hemoptysis, or hematuria.  \n","Because of her abd pain, she went to OSH ED and was transferred \n","to ___ for further care. Per ED report, pt has brief period of \n","confusion - she did not recall the ultrasound or bloodwork at \n","osh. She denies recent drug use or alcohol use. She denies \n","feeling confused, but reports that she is forgetful at times.  \n","In the ED, initial vitals were 98.4 70 106/63 16 97%RA  \n","Labs notable for ALT/AST/AP ___ ___: ___, \n","Tbili1.6, WBC 5K, platelet 77, INR 1.6  \n","\n"," \n","Past Medical History:\n","1. HCV Cirrhosis  \n","2. No history of abnormal Pap smears.  \n","3. She had calcification in her breast, which was removed  \n","previously and per patient not, it was benign.  \n","4. For HIV disease, she is being followed by Dr. ___ Dr.  \n","___.  \n","5. COPD  \n","6. Past history of smoking.  \n","7. She also had a skin lesion, which was biopsied and showed  \n","skin cancer per patient report and is scheduled for a complete  \n","removal of the skin lesion in ___ of this year.  \n","8. She also had another lesion in her forehead with purple  \n","discoloration. It was biopsied to exclude the possibility of  \n","___'s sarcoma, the results is pending.  \n","9. A 15 mm hypoechoic lesion on her ultrasound on ___  \n","and is being monitored by an MRI.  \n","10. History of dysplasia of anus in ___.  \n","11. Bipolar affective disorder, currently manic, mild, and PTSD. \n"," \n","12. History of cocaine and heroin use.  \n","\n"," \n","Social History:\n","___\n","Family History:\n","She a total of five siblings, but she is not  \n","talking to most of them. She only has one brother that she is in \n"," \n","touch with and lives in ___. She is not aware of any  \n","known GI or liver disease in her family.  \n","Her last alcohol consumption was one drink two months ago. No  \n","regular alcohol consumption. Last drug use ___ years ago. She  \n","quit smoking a couple of years ago.  \n","\n"," \n","Physical Exam:\n","VS: 98.1 107/61 78 18 97RA  \n","General: in NAD  \n","HEENT: CTAB, anicteric sclera, OP clear  \n","Neck: supple, no LAD  \n","CV: RRR,S1S2, no m/r/g  \n","Lungs: CTAb, prolonged expiratory phase, no w/r/r  \n","Abdomen: distended, mild diffuse tenderness, +flank dullness, \n","cannot percuss liver/spleen edge ___ distension  \n","GU: no foley  \n","Ext: wwp, no c/e/e, + clubbing  \n","Neuro: AAO3, converse normally, able to recall 3 times after 5 \n","minutes, CN II-XII intact  \n","\n","Discharge:\n","\n","PHYSICAL EXAMINATION:  \n","VS: 98 105/70 95\n","General: in NAD  \n","HEENT: anicteric sclera, OP clear  \n","Neck: supple, no LAD  \n","CV: RRR,S1S2, no m/r/g  \n","Lungs: CTAb, prolonged expiratory phase, no w/r/r  \n","Abdomen: distended but improved, TTP in RUQ, \n","GU: no foley  \n","Ext: wwp, no c/e/e, + clubbing  \n","Neuro: AAO3,  CN II-XII intact  \n","\n"," \n","Pertinent Results:\n","___ 10:25PM   GLUCOSE-109* UREA N-25* CREAT-0.3* SODIUM-138 \n","POTASSIUM-3.4 CHLORIDE-105 TOTAL CO2-27 ANION GAP-9\n","___ 10:25PM   estGFR-Using this\n","___ 10:25PM   ALT(SGPT)-100* AST(SGOT)-114* ALK PHOS-114* \n","TOT BILI-1.6*\n","___ 10:25PM   LIPASE-77*\n","___ 10:25PM   ALBUMIN-3.3*\n","___ 10:25PM   WBC-5.0# RBC-4.29 HGB-14.3 HCT-42.6 MCV-99* \n","MCH-33.3* MCHC-33.5 RDW-15.7*\n","___ 10:25PM   NEUTS-70.3* LYMPHS-16.5* MONOS-8.1 EOS-4.2* \n","BASOS-0.8\n","___ 10:25PM   PLT COUNT-71*\n","___ 10:25PM   ___ PTT-30.9 ___\n","___ 10:25PM   ___\n",".\n","\n","CXR: No acute cardiopulmonary process.  \n","U/S:  \n","1. Nodular appearance of the liver compatible with cirrhosis. \n","Signs of portal  \n","hypertension including small amount of ascites and splenomegaly. \n"," \n","2. Cholelithiasis.  \n","3. Patent portal veins with normal hepatopetal flow.  \n","Diagnostic para attempted in the ED, unsuccessful.  \n","On the floor, pt c/o abd distension and discomfort.\n"," \n","Brief Hospital Course:\n","___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \n","bioplar, PTSD, presented from OSH ED with worsening abd \n","distension over past week and confusion.  \n","\n","# Ascites - p/w worsening abd distension and discomfort for last \n","week. likely ___ portal HTN given underlying liver disease, \n","though no ascitic fluid available on night of admission. No \n","signs of heart failure noted on exam. This was ___ to med \n","non-compliance and lack of diet restriction. SBP negative\n","diuretics:  \n","> Furosemide 40 mg PO DAILY  \n","> Spironolactone 50 mg PO DAILY, chosen over the usual 100mg \n","dose d/t K+ of 4.5.   \n"," CXR was wnl, UA negative, Urine culture blood culture negative. \n"," \n","Pt was losing excess fluid appropriately with stable lytes on \n","the above regimen. Pt was scheduled with current PCP for \n","___ check upon discharge.   \n","Pt was scheduled for new PCP with Dr. ___ at ___ and \n","follow up in Liver clinic to schedule outpatient screening EGD \n","and ___.   \n"," \n","\n"," \n","Medications on Admission:\n","The Preadmission Medication list is accurate and complete.\n","1. Furosemide 20 mg PO DAILY \n","2. Spironolactone 50 mg PO DAILY \n","3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \n","4. Raltegravir 400 mg PO BID \n","5. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n","6. Nicotine Patch 14 mg TD DAILY \n","7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \n","\n"," \n","Discharge Medications:\n","1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \n","2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n","3. Furosemide 40 mg PO DAILY \n","RX *furosemide 40 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet \n","Refills:*3\n","4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \n","5. Nicotine Patch 14 mg TD DAILY \n","6. Raltegravir 400 mg PO BID \n","7. Spironolactone 50 mg PO DAILY \n","8. Acetaminophen 500 mg PO Q6H:PRN pain \n","\n"," \n","Discharge Disposition:\n","Home\n"," \n","Discharge Diagnosis:\n","Ascites from Portal HTN\n","\n"," \n","Discharge Condition:\n","Mental Status: Clear and coherent.\n","Level of Consciousness: Alert and interactive.\n","Activity Status: Ambulatory - Independent.\n","\n"," \n","Discharge Instructions:\n","Dear Ms. ___,\n","It was a pleasure taking care of you! You came to us with \n","stomach pain and worsening distension. While you were here we \n","did a paracentesis to remove 1.5L of fluid from your belly. We \n","also placed you on you 40 mg of Lasix and 50 mg of Aldactone to \n","help you urinate the excess fluid still in your belly. As we \n","discussed, everyone has a different dose of lasix required to \n","make them urinate and it's likely that you weren't taking a high \n","enough dose. Please take these medications daily to keep excess \n","fluid off and eat a low salt diet. You will follow up with Dr. \n","___ in liver clinic and from there have your colonoscopy \n","and EGD scheduled. Of course, we are always here if you need us. \n","We wish you all the best!\n","Your ___ Team.  \n"," \n","Followup Instructions:\n","___\n","\n"," \n","Name:  ___                     Unit No:   ___\n"," \n","Admission Date:  ___              Discharge Date:   ___\n"," \n","Date of Birth:  ___             Sex:   F\n"," \n","Service: MEDICINE\n"," \n","Allergies: \n","No Known Allergies / Adverse Drug Reactions\n"," \n","Attending: ___\n"," \n","Chief Complaint:\n","Worsening ABD distension and pain \n"," \n","Major Surgical or Invasive Procedure:\n","Paracentesis\n","\n"," \n","History of Present Illness:\n","___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \n","bioplar, PTSD, presented from OSH ED with worsening abd \n","distension over past week.  \n","Pt reports self-discontinuing lasix and spirnolactone ___ weeks \n","ago, because she feels like \"they don't do anything\" and that \n","she \"doesn't want to put more chemicals in her.\" She does not \n","follow Na-restricted diets. In the past week, she notes that she \n","has been having worsening abd distension and discomfort. She \n","denies ___ edema, or SOB, or orthopnea. She denies f/c/n/v, d/c, \n","dysuria. She had food poisoning a week ago from eating stale \n","cake (n/v 20 min after food ingestion), which resolved the same \n","day. She denies other recent illness or sick contacts. She notes \n","that she has been noticing gum bleeding while brushing her teeth \n","in recent weeks. she denies easy bruising, melena, BRBPR, \n","hemetesis, hemoptysis, or hematuria.  \n","Because of her abd pain, she went to OSH ED and was transferred \n","to ___ for further care. Per ED report, pt has brief period of \n","confusion - she did not recall the ultrasound or bloodwork at \n","osh. She denies recent drug use or alcohol use. She denies \n","feeling confused, but reports that she is forgetful at times.  \n","In the ED, initial vitals were 98.4 70 106/63 16 97%RA  \n","Labs notable for ALT/AST/AP ___ ___: ___, \n","Tbili1.6, WBC 5K, platelet 77, INR 1.6  \n","\n"," \n","Past Medical History:\n","1. HCV Cirrhosis  \n","2. No history of abnormal Pap smears.  \n","3. She had calcification in her breast, which was removed  \n","previously and per patient not, it was benign.  \n","4. For HIV disease, she is being followed by Dr. ___ Dr.  \n","___.  \n","5. COPD  \n","6. Past history of smoking.  \n","7. She also had a skin lesion, which was biopsied and showed  \n","skin cancer per patient report and is scheduled for a complete  \n","removal of the skin lesion in ___ of this year.  \n","8. She also had another lesion in her forehead with purple  \n","discoloration. It was biopsied to exclude the possibility of  \n","___'s sarcoma, the results is pending.  \n","9. A 15 mm hypoechoic lesion on her ultrasound on ___  \n","and is being monitored by an MRI.  \n","10. History of dysplasia of anus in ___.  \n","11. Bipolar affective disorder, currently manic, mild, and PTSD. \n"," \n","12. History of cocaine and heroin use.  \n","\n"," \n","Social History:\n","___\n","Family History:\n","She a total of five siblings, but she is not  \n","talking to most of them. She only has one brother that she is in \n"," \n","touch with and lives in ___. She is not aware of any  \n","known GI or liver disease in her family.  \n","Her last alcohol consumption was one drink two months ago. No  \n","regular alcohol consumption. Last drug use ___ years ago. She  \n","quit smoking a couple of years ago.  \n","\n"," \n","Physical Exam:\n","VS: 98.1 107/61 78 18 97RA  \n","General: in NAD  \n","HEENT: CTAB, anicteric sclera, OP clear  \n","Neck: supple, no LAD  \n","CV: RRR,S1S2, no m/r/g  \n","Lungs: CTAb, prolonged expiratory phase, no w/r/r  \n","Abdomen: distended, mild diffuse tenderness, +flank dullness, \n","cannot percuss liver/spleen edge ___ distension  \n","GU: no foley  \n","Ext: wwp, no c/e/e, + clubbing  \n","Neuro: AAO3, converse normally, able to recall 3 times after 5 \n","minutes, CN II-XII intact  \n","\n","Discharge:\n","\n","PHYSICAL EXAMINATION:  \n","VS: 98 105/70 95\n","General: in NAD  \n","HEENT: anicteric sclera, OP clear  \n","Neck: supple, no LAD  \n","CV: RRR,S1S2, no m/r/g  \n","Lungs: CTAb, prolonged expiratory phase, no w/r/r  \n","Abdomen: distended but improved, TTP in RUQ, \n","GU: no foley  \n","Ext: wwp, no c/e/e, + clubbing  \n","Neuro: AAO3,  CN II-XII intact  \n","\n"," \n","Pertinent Results:\n","___ 10:25PM   GLUCOSE-109* UREA N-25* CREAT-0.3* SODIUM-138 \n","POTASSIUM-3.4 CHLORIDE-105 TOTAL CO2-27 ANION GAP-9\n","___ 10:25PM   estGFR-Using this\n","___ 10:25PM   ALT(SGPT)-100* AST(SGOT)-114* ALK PHOS-114* \n","TOT BILI-1.6*\n","___ 10:25PM   LIPASE-77*\n","___ 10:25PM   ALBUMIN-3.3*\n","___ 10:25PM   WBC-5.0# RBC-4.29 HGB-14.3 HCT-42.6 MCV-99* \n","MCH-33.3* MCHC-33.5 RDW-15.7*\n","___ 10:25PM   NEUTS-70.3* LYMPHS-16.5* MONOS-8.1 EOS-4.2* \n","BASOS-0.8\n","___ 10:25PM   PLT COUNT-71*\n","___ 10:25PM   ___ PTT-30.9 ___\n","___ 10:25PM   ___\n",".\n","\n","CXR: No acute cardiopulmonary process.  \n","U/S:  \n","1. Nodular appearance of the liver compatible with cirrhosis. \n","Signs of portal  \n","hypertension including small amount of ascites and splenomegaly. \n"," \n","2. Cholelithiasis.  \n","3. Patent portal veins with normal hepatopetal flow.  \n","Diagnostic para attempted in the ED, unsuccessful.  \n","On the floor, pt c/o abd distension and discomfort.\n"," \n","Brief Hospital Course:\n","___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \n","bioplar, PTSD, presented from OSH ED with worsening abd \n","distension over past week and confusion.  \n","\n","# Ascites - p/w worsening abd distension and discomfort for last \n","week. likely ___ portal HTN given underlying liver disease, \n","though no ascitic fluid available on night of admission. No \n","signs of heart failure noted on exam. This was ___ to med \n","non-compliance and lack of diet restriction. SBP negative\n","diuretics:  \n","> Furosemide 40 mg PO DAILY  \n","> Spironolactone 50 mg PO DAILY, chosen over the usual 100mg \n","dose d/t K+ of 4.5.   \n"," CXR was wnl, UA negative, Urine culture blood culture negative. \n"," \n","Pt was losing excess fluid appropriately with stable lytes on \n","the above regimen. Pt was scheduled with current PCP for \n","___ check upon discharge.   \n","Pt was scheduled for new PCP with Dr. ___ at ___ and \n","follow up in Liver clinic to schedule outpatient screening EGD \n","and ___.   \n"," \n","\n"," \n","Medications on Admission:\n","The Preadmission Medication list is accurate and complete.\n","1. Furosemide 20 mg PO DAILY \n","2. Spironolactone 50 mg PO DAILY \n","3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \n","4. Raltegravir 400 mg PO BID \n","5. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n","6. Nicotine Patch 14 mg TD DAILY \n","7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \n","\n"," \n","Discharge Medications:\n","1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \n","2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n","3. Furosemide 40 mg PO DAILY \n","RX *furosemide 40 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet \n","Refills:*3\n","4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \n","5. Nicotine Patch 14 mg TD DAILY \n","6. Raltegravir 400 mg PO BID \n","7. Spironolactone 50 mg PO DAILY \n","8. Acetaminophen 500 mg PO Q6H:PRN pain \n","\n"," \n","Discharge Disposition:\n","Home\n"," \n","Discharge Diagnosis:\n","Ascites from Portal HTN\n","\n"," \n","Discharge Condition:\n","Mental Status: Clear and coherent.\n","Level of Consciousness: Alert and interactive.\n","Activity Status: Ambulatory - Independent.\n","\n"," \n","Discharge Instructions:\n","Dear Ms. ___,\n","It was a pleasure taking care of you! You came to us with \n","stomach pain and worsening distension. While you were here we \n","did a paracentesis to remove 1.5L of fluid from your belly. We \n","also placed you on you 40 mg of Lasix and 50 mg of Aldactone to \n","help you urinate the excess fluid still in your belly. As we \n","discussed, everyone has a different dose of lasix required to \n","make them urinate and it's likely that you weren't taking a high \n","enough dose. Please take these medications daily to keep excess \n","fluid off and eat a low salt diet. You will follow up with Dr. \n","___ in liver clinic and from there have your colonoscopy \n","and EGD scheduled. Of course, we are always here if you need us. \n","We wish you all the best!\n","Your ___ Team.  \n"," \n","Followup Instructions:\n","___\n","\n"]}]},{"cell_type":"code","source":["import pandas as pd\n","\n","# 출력 옵션 변경\n","pd.set_option(\"display.max_columns\", None)   # 모든 칼럼 출력\n","pd.set_option(\"display.max_colwidth\", None)  # 텍스트 잘리지 않게\n","pd.set_option(\"display.expand_frame_repr\", False)  # 줄바꿈 없이 한 줄에\n","\n","# 다시 확인\n","print(df.head(5))\n"],"metadata":{"id":"blMiDilRjG_H"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["print(df[[\"note_id\",\"subject_id\",\"hadm_id\",\"text\"]].head(3))\n"],"metadata":{"id":"7Sc4pGSkjXyN"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["print(df[[\"text\"]]).head(3)"],"metadata":{"id":"YXhFNHLKjgu8"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["import pandas as pd\n","\n","pd.set_option('display.max_colwidth', None)  # 컬럼 길이 제한 해제\n","# 필요하면 행 수도 조금만 보여주세요\n","display(df['text'].head(3))                 # 첫 3개 텍스트 그대로 표시\n"],"metadata":{"id":"12e9cj10HGyd"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df['text_clean'] = (\n","    df['text']\n","      .str.replace(r'[\\r\\n]+', ' ', regex=True)  # \\r, \\n 모두 공백으로\n","      .str.replace(r'\\s+', ' ', regex=True)      # 중복 공백 정리\n","      .str.strip()\n",")\n"],"metadata":{"id":"7_Gw-OpgHgxo"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["pd.set_option('display.max_colwidth', None)  # 컬럼 길이 제한 해제\n","# 필요하면 행 수도 조금만 보여주세요\n","display(df['text_clean'].head(3))"],"metadata":{"id":"44rocqYoNjsJ"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# Mimic_3.1 Datasets"],"metadata":{"id":"bm5edIdpyQPj"}},{"cell_type":"code","source":["import pandas as pd\n","\n","file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/labevents.csv\"\n","df = pd.read_csv(file_path, nrows=100)\n","print(df.head())\n"],"metadata":{"id":"Wg5wutRxNmiT"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["### labevents.csv_10000032"],"metadata":{"id":"CDoSvluU5m6r"}},{"cell_type":"code","source":["!pip -q install duckdb\n","\n","import duckdb\n","con = duckdb.connect()\n","\n","file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/labevents.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/labevents_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"vxK9QX3kyHSL"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["!pip -q install duckdb\n","\n","import duckdb\n","con = duckdb.connect()\n","\n","file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/transfers.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/transfers_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"aWrQ0oOo06vb"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["!pip -q install duckdb\n","\n","import duckdb\n","con = duckdb.connect()\n","\n","file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/services.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/services_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"Jk2q6BMW565-"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/procedures_icd.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/procedures_icd_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"SV0hJk166U__"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/prescriptions.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/prescriptions_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"pcLoh4R76yUh"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/poe.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/poe_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"Gry8JBB57QvR"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/poe_detail.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/poe_detail_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"cRCq7B4U7zfJ"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["# 전제: duckdb 설치 & con = duckdb.connect() 완료 상태\n","import os\n","import duckdb\n","\n","file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/pharmacy.csv\"\n","out_path  = \"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/pharmacy_subject_10000032.csv\"\n","\n","# 출력 폴더 없으면 생성\n","os.makedirs(os.path.dirname(out_path), exist_ok=True)\n","\n","# 모든 컬럼을 우선 문자열로 읽고( all_varchar=1 ), 파일 전체 스캔( sample_size=-1 )\n","# 문자열이 섞인 열(예: fill_quantity='q12h') 때문에 타입 추론이 깨지는 걸 방지\n","df = duckdb.connect().execute(f\"\"\"\n","WITH raw AS (\n","  SELECT *\n","  FROM read_csv_auto('{file_path}', all_varchar=1, sample_size=-1)\n",")\n","SELECT *\n","FROM raw\n","WHERE TRY_CAST(subject_id AS BIGINT) = 10000032\n","\"\"\").df()\n","\n","# 저장\n","df.to_csv(out_path, index=False)\n","\n","# 확인용 미리보기\n","df.head()\n"],"metadata":{"id":"6niPu9G68P82"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/patients.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/patients_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"dBTXw_Hb8kw8"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/omr.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/omr_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"w9mOMoRHeL00"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/microbiologyevents.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/microbiologyevents_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"AoI7A4LreQur"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/hcpcsevents.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/hcpcsevents_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"s4bZHusveWSH"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/emar.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/emar_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"bFfkylauee8r"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["import os\n","import duckdb\n","\n","file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/emar_detail.csv\"\n","out_path  = \"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/emar_detail_subject_10000032.csv\"\n","\n","# 저장 폴더 없으면 생성\n","os.makedirs(os.path.dirname(out_path), exist_ok=True)\n","\n","# 모든 컬럼 문자열로 읽기(all_varchar=1) + 전체 스캔(sample_size=-1)\n","# subject_id는 문자열이므로 필터 시 숫자로 안전 변환(TRY_CAST)\n","df = con.execute(f\"\"\"\n","WITH raw AS (\n","  SELECT *\n","  FROM read_csv_auto('{file_path}', all_varchar=1, sample_size=-1)\n",")\n","SELECT *\n","FROM raw\n","WHERE TRY_CAST(subject_id AS BIGINT) = 10000032\n","\"\"\").df()\n","\n","# 저장 및 확인\n","df.to_csv(out_path, index=False)\n","df.head()\n"],"metadata":{"id":"NxVLsKHBemjy"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/drgcodes.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/drgcodessubject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"5eJF5-oferjo"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/diagnoses_icd.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/diagnoses_icd_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"5TK7NgTneyT9"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/d_labitems.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/d_labitems_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"gt2uq0f1e6Rr"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["file_path = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp/admissions.csv\"\n","\n","df = con.execute(f\"\"\"\n","    SELECT *\n","    FROM read_csv_auto('{file_path}')\n","    WHERE subject_id = 10000032\n","\"\"\").df()\n","\n","# 필요시 저장\n","df.to_csv(\"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/admissions_subject_10000032.csv\", index=False)\n","df.head()\n"],"metadata":{"id":"2-QJ8Vmwe-ep"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["## subject_id=10000032인 모든 칼럼 합치는 코드"],"metadata":{"id":"oTvHY8FQmn8c"}},{"cell_type":"code","source":["import os\n","from glob import glob\n","import duckdb\n","import pandas as pd\n","\n","# DuckDB 연결 (메모리)\n","con = duckdb.connect()\n","\n","# 입력 폴더와 출력 파일\n","in_dir   = \"/content/drive/MyDrive/DILAB/MARS/mimiciv_3.1/files/hosp\"\n","out_path = \"/content/drive/MyDrive/DILAB/OK/DI_LAB/MARS_Datathon/Datasets/subject_10000032_all.csv\"\n","os.makedirs(os.path.dirname(out_path), exist_ok=True)\n","\n","# 폴더 내 CSV 모두 대상\n","csv_files = sorted(glob(os.path.join(in_dir, \"*.csv\")))\n","\n","frames = []\n","for fp in csv_files:\n","    # 1) 현재 파일의 컬럼 목록 살펴보기 (DuckDB에서 스키마 추론만)\n","    schema = con.execute(f\"\"\"\n","        DESCRIBE SELECT * FROM read_csv_auto('{fp}', all_varchar=1, sample_size=20480)\n","    \"\"\").df()\n","    cols_lower = set(schema[\"column_name\"].str.lower().tolist())\n","\n","    # 2) subject_id가 없는 파일(d_labitems 같은 사전테이블)은 스킵\n","    if \"subject_id\" not in cols_lower:\n","        # 필요하면 여기서 print(f\"skip: {os.path.basename(fp)} (no subject_id)\") 해도 됨\n","        continue\n","\n","    # 3) subject_id=10000032만 필터해서 읽기 (전 컬럼 문자열 + 전체 스캔)\n","    #    \"___\" 같은 토큰을 결측으로 보고 싶으면 nullstr 옵션에 추가\n","    q = f\"\"\"\n","    WITH raw AS (\n","      SELECT *\n","      FROM read_csv_auto('{fp}', all_varchar=1, sample_size=-1, nullstr=['', 'NULL', 'NaN', '___'])\n","    )\n","    SELECT *, '{os.path.basename(fp)}' AS source_file\n","    FROM raw\n","    WHERE TRY_CAST(subject_id AS BIGINT) = 10000032\n","    \"\"\"\n","    part = con.execute(q).df()\n","\n","    if len(part):\n","        frames.append(part)\n","\n","# 4) 파일별 결과를 '열 합집합'으로 세로 결합\n","if frames:\n","    combined = pd.concat(frames, axis=0, join=\"outer\", ignore_index=True)\n","    combined.to_csv(out_path, index=False)\n","    print(f\"완료! 행수={len(combined):,}  저장: {out_path}\")\n","    display(combined.head(10))\n","else:\n","    print(\"subject_id=10000032 데이터가 포함된 파일이 없습니다.\")\n"],"metadata":{"id":"iYSAWoOchIi2"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":[],"metadata":{"id":"LFgTvqComvpk"},"execution_count":null,"outputs":[]}]}